HOW LONG SHOULD GOLIMUMAB TREATMENT BE CONTINUED IN PATIENTS WITH ULCERATIVE COLITIS WHO DO NOT RESPOND TO INITIAL INDUCTION THERAPY?

Paul Rutgeerts  1     Walter Reinisch  2     Brian G. Feagan  3     William Sandborn  4     Dino Tarabar  5     Zbigniew Hebzda  6     Ruji Yao  7     Colleen W. Marano     Richard S Strauss    
1 University Hospital Gasthuisberg, Leuven, Belgium
2 Mcmaster University, Hamilton, Canada
3 U Western Ontario, London, Canada
4 University Of California San Diego, La Jolla, United States
5 Military Medical Academy, Belgrade, Serbia
6 Wojskowy Szpital Kliniczny Z Poliklinika, Krakow, Poland
7 Merck & Co., Inc., Whitehouse Station,

Conference
UEG Week 2014

Citation
United European Gastroenterology Journal; 2014: 2 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing